Trial Profile
A prospective, open, multicenter, non-comparative study to evaluate the efficacy of olmesartan-medoxomil combined with amlodipine in patients with hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 21 Dec 2015 New trial record